Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis

about

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis

Item

http://www.wikidata.org/entity/Q36265568

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@ast

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@en

type

Item

label

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@ast

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@en

prefLabel

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@ast

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@en

P1476

Cost-Utility Analysis of Mycop ...... Proliferative Lupus Nephritis

@en

P2093

Christina M Yuan

http://www.w3.org/2001/XMLSchema#string

Dustin J Little

http://www.w3.org/2001/XMLSchema#string

Ian Rivera

http://www.w3.org/2001/XMLSchema#string

Robert Nee

http://www.w3.org/2001/XMLSchema#string

P2860

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Increased risk of death in pediatric and adult patients with ESRD secondary to lupus

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.

A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.

Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?

Diagnosis and treatment of lupus nephritis flares--an update.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

P304

917567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/917567

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Kevin C. Abbott

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283336525

http://www.w3.org/2001/XMLSchema#string

P698

26600951

http://www.w3.org/2001/XMLSchema#string

P932

4639665

http://www.w3.org/2001/XMLSchema#string